Product Information
XELJANZ 5 MG TABLET is a brand product labeled by Pfizer Inc., priced at $73.5726 per EA under NDC 00069100101. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Pfizer Inc.NDC
00069100101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOFACITINIB CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA203214On Market Since
11/9/2012
Pharmacological Classes
Price Statistics
The NADAC for XELJANZ 5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 121.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $73.5726 per EA |
|---|---|
| All-time high | $98.5905 (Jun 11, 2025) |
| All-time low | $33.2872 (Nov 28, 2013) |
| 52-week high | $98.4538 |
| 52-week low | $73.5726 |
| Median price | $73.8329 |
| Average price | $71.0309 |
| Largest weekly change | -25.0% (Dec 31, 2025) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the tofacitinib market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XELJANZ 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XELJANZ 5 MG TABLET, manufactured by Pfizer Inc., is $73.5726 per EA (NDC 00069100101), effective Jun 24, 2026.
How has the price of XELJANZ 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for XELJANZ 5 MG TABLET has risen 121.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for XELJANZ 5 MG TABLET?
Since Nov 28, 2013, the NADAC for XELJANZ 5 MG TABLET has ranged from a low of $33.2872 (Nov 28, 2013) to a high of $98.5905 (Jun 11, 2025), with a median of $73.8329 per EA.
Are there cheaper alternatives to XELJANZ 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XELJANZ 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures XELJANZ 5 MG TABLET?
XELJANZ 5 MG TABLET (NDC 00069100101) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification